Bottom line
MJCXX vs PWJZX: the short answer
MJCXX (PGIM Government Money Market Fund) and PWJZX (PGIM Jennison International Opportunities Fund) are both money market funds.
MJCXX is cheaper at 0.73% vs 0.9% — a difference of $17 a year per $10,000 invested.
Over five years, PWJZX returned +7.4% a year vs +2.8% for MJCXX (reporting dates differ).
Updated Nov 19, 2026
MJCXX vs PWJZX side by side
| MJCXX | PWJZX | |
|---|---|---|
| Type | Money market fund | Mutual fund |
| Fund family | PGIM (Prudential) | PGIM (Prudential) |
| Category | Money Market | International Stock |
| Expense ratio | 0.73% | 0.9% |
| Annual cost per $10k | $73 | $90 |
| 10-yr cost on $10k (prospectus) | $860 | $1,162 |
| Max front load | 0% | 0% |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +3.6% | +6.8% |
| 5-yr return (annualized) | +2.8% | +7.4% |
| 10-yr return (annualized) | +1.7% | +9.2% |
| Best quarter | — | +33.3% |
| Worst quarter | — | −21.5% |
| Net assets (fund) | — | $4.6B |
| Number of holdings | — | 41 |
| Portfolio turnover | — | 81% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
MJCXX and PWJZX share none of their top holdings.
MJCXX top 10
PWJZX top 10
- Taiwan Semiconductor Manufacturing Company Ltd — 7.48%
- Asml Holding Nv — 5.42%
- Galderma Group Ag — 4.69%
- Safran Sa — 4.02%
- Rolls-royce Holdings Plc — 3.91%
- Advantest Corp — 3.88%
- Abb Ltd (ch) — 3.54%
- Samsung Electronics Co Ltd — 3.41%
- Compagnie Financiere Richemont Sa — 3.37%
- Argenx Se — 3.26%
FAQ
What is the difference between MJCXX and PWJZX?
MJCXX (PGIM Government Money Market Fund) and PWJZX (PGIM Jennison International Opportunities Fund) are both money market funds. MJCXX is cheaper at 0.73% vs 0.9% — a difference of $17 a year per $10,000 invested.
Which is cheaper, MJCXX or PWJZX?
MJCXX has the lower expense ratio (0.73%).
Should I own both MJCXX and PWJZX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.